Artwork

Peter Attia, MD, Peter Attia, and MD에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Peter Attia, MD, Peter Attia, and MD 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!

#289 - AMA #56: Cancer screening: pros and cons, screening options, interpreting results, and more

20:44
 
공유
 

Manage episode 400526643 series 2432666
Peter Attia, MD, Peter Attia, and MD에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Peter Attia, MD, Peter Attia, and MD 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

Sign Up to Receive Peter’s Weekly Newsletter

In this “Ask Me Anything” (AMA) episode, the conversation focuses on cancer screening, a topic often shrouded in confusion yet crucial to understand given that early identification of a cancer is an essential part of survival strategy. Peter examines the arguments both for and against cancer screening, including addressing why some trials may show no benefit to screening. He then delves into the various screening modalities available for different cancers, highlights the pros and cons associated with each, and explains how to interpret the results. Additionally, Peter provides guidance for navigating outside of the relatively narrow and confined screening guidelines for various types of screening tests.

If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #56 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

We discuss:

  • Why understanding cancer screening is crucial [2:45];
  • The prevalence of cancer diagnosis and mortality rates [4:30];
  • Why cancer screening and early detection is such an important part of the strategy to survive a cancer diagnosis [11:00];
  • Data on how cancer screening impacts survivability of cancer [16:30];
  • Inconsistencies between cancer screening trials regarding benefits to survival rates [25:45];
  • What are some of the reasons why clinical trials don’t always improve cancer-specific mortality? [30:15];
  • What are the arguments against population-level cancer screening? [42:00];
  • Cancer screening outside the recommended guidelines: risks and benefits, interpreting results, and other considerations [46:00];
  • Understanding sensitivity and specificity when reviewing screening results [52:30];
  • Risks and complications associated with colonoscopies [55:45];
  • Cancer screening modalities: options for cancer screening both within standard recommendations and beyond [58:30];
  • The strengths and limitations of various types of cancer screening [1:02:15];
  • Understanding positive and negative predictive value using sensitivity, specificity, and pretest probability [1:11:45];
  • Factors that influence an individual's pretest probability of cancer [1:13:45];
  • How to interpret cancer screening results [1:18:15];
  • The importance of having an advocate when considering out-of-guideline cancer screening tests [1:23:30];
  • How stacking multiple cancer screening modalities can decrease the risk of false positives [1:29:30];
  • Advice and guidance for making decisions related to cancer screening [1:31:15]; and
  • More.

Connect With Peter on Twitter, Instagram, Facebook and YouTube

  continue reading

351 에피소드

Artwork
icon공유
 
Manage episode 400526643 series 2432666
Peter Attia, MD, Peter Attia, and MD에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Peter Attia, MD, Peter Attia, and MD 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

Sign Up to Receive Peter’s Weekly Newsletter

In this “Ask Me Anything” (AMA) episode, the conversation focuses on cancer screening, a topic often shrouded in confusion yet crucial to understand given that early identification of a cancer is an essential part of survival strategy. Peter examines the arguments both for and against cancer screening, including addressing why some trials may show no benefit to screening. He then delves into the various screening modalities available for different cancers, highlights the pros and cons associated with each, and explains how to interpret the results. Additionally, Peter provides guidance for navigating outside of the relatively narrow and confined screening guidelines for various types of screening tests.

If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #56 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

We discuss:

  • Why understanding cancer screening is crucial [2:45];
  • The prevalence of cancer diagnosis and mortality rates [4:30];
  • Why cancer screening and early detection is such an important part of the strategy to survive a cancer diagnosis [11:00];
  • Data on how cancer screening impacts survivability of cancer [16:30];
  • Inconsistencies between cancer screening trials regarding benefits to survival rates [25:45];
  • What are some of the reasons why clinical trials don’t always improve cancer-specific mortality? [30:15];
  • What are the arguments against population-level cancer screening? [42:00];
  • Cancer screening outside the recommended guidelines: risks and benefits, interpreting results, and other considerations [46:00];
  • Understanding sensitivity and specificity when reviewing screening results [52:30];
  • Risks and complications associated with colonoscopies [55:45];
  • Cancer screening modalities: options for cancer screening both within standard recommendations and beyond [58:30];
  • The strengths and limitations of various types of cancer screening [1:02:15];
  • Understanding positive and negative predictive value using sensitivity, specificity, and pretest probability [1:11:45];
  • Factors that influence an individual's pretest probability of cancer [1:13:45];
  • How to interpret cancer screening results [1:18:15];
  • The importance of having an advocate when considering out-of-guideline cancer screening tests [1:23:30];
  • How stacking multiple cancer screening modalities can decrease the risk of false positives [1:29:30];
  • Advice and guidance for making decisions related to cancer screening [1:31:15]; and
  • More.

Connect With Peter on Twitter, Instagram, Facebook and YouTube

  continue reading

351 에피소드

Wszystkie odcinki

×
 
Loading …

플레이어 FM에 오신것을 환영합니다!

플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.

 

빠른 참조 가이드